Zimmer Biomet Announces Fourth Quarter and Full-Year 2025 Financial Results

Go back to Zimmer Biomet Announces Fourth Quarter and Full-Year 2025 Financial Results

Zimmer Biomet Holdings (ZBH) Tops Q4 EPS by 2c, Beats on Revenue; Offers FY26 EPS Guidance

February 10, 2026 6:32 AM EST

Zimmer Biomet Holdings (NYSE: ZBH) reported Q4 EPS of $2.42, $0.02 better than the analyst estimate of $2.40. Revenue for the quarter came in at $2.24 billion versus the consensus estimate of $2.22 billion.

GUIDANCE:

Zimmer Biomet Holdings sees FY2026 EPS of $8.30-$8.45, versus the... More